The report covers a detailed analysis and forecast for the global magnetic resonance imaging (mri) contrast agents market on a global and regional level from 2021 to 2028. The study offers historical data from 2016 to 2020 along with a forecast from 2021 to 2028 based on revenue (USD Million). The study comprises a comprehensive view of the market with a review of market drivers, restraints, and opportunities. It also provides the level of impact of drivers and restraints on the magnetic resonance imaging (mri) contrast agents market between 2021 and 2028.
These assessments help users of the report to analyze the magnetic resonance imaging (mri) contrast agents market on the basis of different metrics that includes brand loyalty, switching costs, capital investments, economies of scale, regulatory legislation, current sales networks, production rights and patents, customer preferences, and promotional effects. This categorized data is expected to aid industry stakeholders in decision-making.The study also suggests company penetration plans for new entrants. Furthermore, the magnetic resonance imaging (mri) contrast agents industry study report has listed the main manufacturers and distributors operating in all the major regions. We anticipate that this analysis and data will assist industry players to strengthen their networks of market penetration and expand their geographical breadth as a result of their efforts.
Market Research Store (MRS) published a latest report titled “Magnetic Resonance Imaging (MRI) Contrast Agents Market research report which is segmented by Products (Extracellular fluid agents, Blood pool agents, Target/organ-specific agents), by Applications (Diagnostic Imaging, Others), by Key Players/Companies (Bayer, Ratiopharm, Agfa Healthcare, Liebel-Flarsheim Company LLC, GE Healthcare, Guerbet LLC, Bracco Diagnostics Inc)”. In 2020, the global magnetic resonance imaging (mri) contrast agents market demand was registered at XX (USD Million) and is predicted to reach XX (USD Million) at a CAGR of XX% by 2028.
| Report Attributes | Report Details |
|---|---|
| Report Title | Magnetic Resonance Imaging (MRI) Contrast Agents Market Research Report |
| By Products | Extracellular fluid agents, Blood pool agents, Target/organ-specific agents |
| By Applications | Diagnostic Imaging, Others |
| By Key Players | Bayer, Ratiopharm, Agfa Healthcare, Liebel-Flarsheim Company LLC, GE Healthcare, Guerbet LLC, Bracco Diagnostics Inc |
| Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East And Africa (MEA) |
| Countries Covered | North America : U.S and Canada Europe : U.K, Spain, Germany, Italy, Russia, France, Rest of Europe APAC : Japan, India, China, Australia, South Korea, South East Asia, Rest of Asia Pacific Latin America : Mexico, Brazil The Middle East And Africa : South Africa, UAE, Saudi Arab, Rest of MEA |
| Base Year | 2020 |
| Historical Year | 2016to 2020 (Depending on availability, data from 2010 can be offered) |
| Forecast Year | 2028 |
| Number of Pages | 103 |
| Customization Available | Yes, the report can be tailored to meet your specific requirements. |
The study includes a detailed competitive scenario and product portfolio of key vendors. The report evaluates Porter’s Five Forces model to analyze the different factors affecting the growth of the magnetic resonance imaging (mri) contrast agents market. Furthermore, the study encompasses a market attractiveness analysis, which provides the most attractive and least attractive market segments information by products, applications, and region. Additionally, the report also covers the exhaustive regulatory landscape, technology landscape, value chain analysis and PEST analysis.
Request Free Sample
Request Free Sample
The epidemic of COVID-19 has caused significant economic and social upheaval. The pandemic has had an influence on the supply chain and value chain of numerous businesses. The magnetic resonance imaging (mri) contrast agents market is not an exception. The impact of the COVID-19 pandemic will be analyzed on the basis of the overall industry including both the demand side and supply side perspectives. The effects of the pandemic would be studied and analyzed for short-term and long-term scenarios. This would assist to formulate business strategies for the period during the pandemic as well as the post-pandemic period for all stakeholders involved in the industry including suppliers, manufacturers, vendors, distributors, and end-users.
The report study delivers a critical assessment on the magnetic resonance imaging (mri) contrast agents by segmenting the total addressable market based on products, applications, and region. All the segments & categories of the magnetic resonance imaging (mri) contrast agents market are evaluated on the basis of past and future trends. The data for the market and its segments & categories are provided from 2016 to 2028. The report has identified the important segments & categories offering the most to the total addressable market growth in terms of revenue as well as the factors advancing their development.
The report includes a detailed segment analysis of the magnetic resonance imaging (mri) contrast agents market based on products, applications, and region. On the basis of Products, the market can be classified into Extracellular fluid agents, Blood pool agents, Target/organ-specific agents. Based on the Applications, the market can be segmented into the Diagnostic Imaging, Others.
The report provides exhaustive information on all the key players in the industry based on company overview, company market share, recent developments, business strategies, and financial performance among others. The report will also provide an extensive product portfolio for each company along with detailed descriptions/features. This report also contains useful recommendations for both established and new players around the world.
Some of the key players in the magnetic resonance imaging (mri) contrast agents market include:
Due to the existence of multiple significant competitors, the industry is very competitive. Several inorganic growth techniques, such as acquisitions, mergers, and regional expansion are being pursued by the majority of manufacturers in order to increase their market share and obtain a competitive edge.
The report provides market size for all the segments and their categories for regions that include North America, Europe, Asia Pacific (APAC), Latin America and the Middle East & Africa (MEA). These regions are further bifurcated into major countries including the U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others. The report has analyzed both developed & developing regions considered for research of the magnetic resonance imaging (mri) contrast agents market. To assist firms in developing effective development strategies, the regional analysis section provides a complete overview of the industry from a number of countries and regions.
Request Free SampleINQUIRY_TEXT
The findings would be further affirmed and expanded upon through primary research conducted with industry professionals and decision-makers from around the world. A wide range of data validation and market estimation approaches were used to further assemble and validate the results gathered during the research. We also have our data forecasting algorithm that projects market growth over the year 2028. We performed both primary and secondary research to gain a clear overview of the magnetic resonance imaging (mri) contrast agents market. This helped us understand existing market dynamics like supply-demand imbalance, pricing trends, product preferences, consumer behavior, and other factors.
Table of Content 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Regulatory Scenario by Region/Country 1.4 Market Investment Scenario Strategic 1.5 Market Analysis by Type 1.5.1 Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Share by Type (2020-2026) 1.5.2 Extracellular fluid agents 1.5.3 Blood pool agents 1.5.4 Target/organ-specific agents 1.6 Market by Application 1.6.1 Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Share by Application (2020-2026) 1.6.2 Diagnostic Imaging 1.6.3 Others 1.7 Magnetic Resonance Imaging (MRI) Contrast Agents Industry Development Trends under COVID-19 Outbreak 1.7.1 Global COVID-19 Status Overview 1.7.2 Influence of COVID-19 Outbreak on Magnetic Resonance Imaging (MRI) Contrast Agents Industry Development 2. Global Market Growth Trends 2.1 Industry Trends 2.1.1 SWOT Analysis 2.1.2 Porter’s Five Forces Analysis 2.2 Potential Market and Growth Potential Analysis 2.3 Industry News and Policies by Regions 2.3.1 Industry News 2.3.2 Industry Policies 2.4 Industry Trends Under COVID-19 3 Value Chain of Magnetic Resonance Imaging (MRI) Contrast Agents Market 3.1 Value Chain Status 3.2 Magnetic Resonance Imaging (MRI) Contrast Agents Manufacturing Cost Structure Analysis 3.2.1 Production Process Analysis 3.2.2 Manufacturing Cost Structure of Magnetic Resonance Imaging (MRI) Contrast Agents 3.2.3 Labor Cost of Magnetic Resonance Imaging (MRI) Contrast Agents 3.2.3.1 Labor Cost of Magnetic Resonance Imaging (MRI) Contrast Agents Under COVID-19 3.3 Sales and Marketing Model Analysis 3.4 Downstream Major Customer Analysis (by Region) 3.5 Value Chain Status Under COVID-19 4 Players Profiles 4.1 Bayer 4.1.1 Bayer Basic Information 4.1.2 Magnetic Resonance Imaging (MRI) Contrast Agents Product Profiles, Application and Specification 4.1.3 Bayer Magnetic Resonance Imaging (MRI) Contrast Agents Market Performance (2015-2020) 4.1.4 Bayer Business Overview 4.2 Ratiopharm 4.2.1 Ratiopharm Basic Information 4.2.2 Magnetic Resonance Imaging (MRI) Contrast Agents Product Profiles, Application and Specification 4.2.3 Ratiopharm Magnetic Resonance Imaging (MRI) Contrast Agents Market Performance (2015-2020) 4.2.4 Ratiopharm Business Overview 4.3 Agfa Healthcare 4.3.1 Agfa Healthcare Basic Information 4.3.2 Magnetic Resonance Imaging (MRI) Contrast Agents Product Profiles, Application and Specification 4.3.3 Agfa Healthcare Magnetic Resonance Imaging (MRI) Contrast Agents Market Performance (2015-2020) 4.3.4 Agfa Healthcare Business Overview 4.4 Liebel-Flarsheim Company LLC 4.4.1 Liebel-Flarsheim Company LLC Basic Information 4.4.2 Magnetic Resonance Imaging (MRI) Contrast Agents Product Profiles, Application and Specification 4.4.3 Liebel-Flarsheim Company LLC Magnetic Resonance Imaging (MRI) Contrast Agents Market Performance (2015-2020) 4.4.4 Liebel-Flarsheim Company LLC Business Overview 4.5 GE Healthcare 4.5.1 GE Healthcare Basic Information 4.5.2 Magnetic Resonance Imaging (MRI) Contrast Agents Product Profiles, Application and Specification 4.5.3 GE Healthcare Magnetic Resonance Imaging (MRI) Contrast Agents Market Performance (2015-2020) 4.5.4 GE Healthcare Business Overview 4.6 Guerbet LLC 4.6.1 Guerbet LLC Basic Information 4.6.2 Magnetic Resonance Imaging (MRI) Contrast Agents Product Profiles, Application and Specification 4.6.3 Guerbet LLC Magnetic Resonance Imaging (MRI) Contrast Agents Market Performance (2015-2020) 4.6.4 Guerbet LLC Business Overview 4.7 Bracco Diagnostics Inc 4.7.1 Bracco Diagnostics Inc Basic Information 4.7.2 Magnetic Resonance Imaging (MRI) Contrast Agents Product Profiles, Application and Specification 4.7.3 Bracco Diagnostics Inc Magnetic Resonance Imaging (MRI) Contrast Agents Market Performance (2015-2020) 4.7.4 Bracco Diagnostics Inc Business Overview 5 Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Analysis by Regions 5.1 Global Magnetic Resonance Imaging (MRI) Contrast Agents Sales, Revenue and Market Share by Regions 5.1.1 Global Magnetic Resonance Imaging (MRI) Contrast Agents Sales by Regions (2015-2020) 5.1.2 Global Magnetic Resonance Imaging (MRI) Contrast Agents Revenue by Regions (2015-2020) 5.2 North America Magnetic Resonance Imaging (MRI) Contrast Agents Sales and Growth Rate (2015-2020) 5.3 Europe Magnetic Resonance Imaging (MRI) Contrast Agents Sales and Growth Rate (2015-2020) 5.4 Asia-Pacific Magnetic Resonance Imaging (MRI) Contrast Agents Sales and Growth Rate (2015-2020) 5.5 Middle East and Africa Magnetic Resonance Imaging (MRI) Contrast Agents Sales and Growth Rate (2015-2020) 5.6 South America Magnetic Resonance Imaging (MRI) Contrast Agents Sales and Growth Rate (2015-2020) 6 North America Magnetic Resonance Imaging (MRI) Contrast Agents Market Analysis by Countries 6.1 North America Magnetic Resonance Imaging (MRI) Contrast Agents Sales, Revenue and Market Share by Countries 6.1.1 North America Magnetic Resonance Imaging (MRI) Contrast Agents Sales by Countries (2015-2020) 6.1.2 North America Magnetic Resonance Imaging (MRI) Contrast Agents Revenue by Countries (2015-2020) 6.1.3 North America Magnetic Resonance Imaging (MRI) Contrast Agents Market Under COVID-19 6.2 United States Magnetic Resonance Imaging (MRI) Contrast Agents Sales and Growth Rate (2015-2020) 6.2.1 United States Magnetic Resonance Imaging (MRI) Contrast Agents Market Under COVID-19 6.3 Canada Magnetic Resonance Imaging (MRI) Contrast Agents Sales and Growth Rate (2015-2020) 6.4 Mexico Magnetic Resonance Imaging (MRI) Contrast Agents Sales and Growth Rate (2015-2020) 7 Europe Magnetic Resonance Imaging (MRI) Contrast Agents Market Analysis by Countries 7.1 Europe Magnetic Resonance Imaging (MRI) Contrast Agents Sales, Revenue and Market Share by Countries 7.1.1 Europe Magnetic Resonance Imaging (MRI) Contrast Agents Sales by Countries (2015-2020) 7.1.2 Europe Magnetic Resonance Imaging (MRI) Contrast Agents Revenue by Countries (2015-2020) 7.1.3 Europe Magnetic Resonance Imaging (MRI) Contrast Agents Market Under COVID-19 7.2 Germany Magnetic Resonance Imaging (MRI) Contrast Agents Sales and Growth Rate (2015-2020) 7.2.1 Germany Magnetic Resonance Imaging (MRI) Contrast Agents Market Under COVID-19 7.3 UK Magnetic Resonance Imaging (MRI) Contrast Agents Sales and Growth Rate (2015-2020) 7.3.1 UK Magnetic Resonance Imaging (MRI) Contrast Agents Market Under COVID-19 7.4 France Magnetic Resonance Imaging (MRI) Contrast Agents Sales and Growth Rate (2015-2020) 7.4.1 France Magnetic Resonance Imaging (MRI) Contrast Agents Market Under COVID-19 7.5 Italy Magnetic Resonance Imaging (MRI) Contrast Agents Sales and Growth Rate (2015-2020) 7.5.1 Italy Magnetic Resonance Imaging (MRI) Contrast Agents Market Under COVID-19 7.6 Spain Magnetic Resonance Imaging (MRI) Contrast Agents Sales and Growth Rate (2015-2020) 7.6.1 Spain Magnetic Resonance Imaging (MRI) Contrast Agents Market Under COVID-19 7.7 Russia Magnetic Resonance Imaging (MRI) Contrast Agents Sales and Growth Rate (2015-2020) 7.7.1 Russia Magnetic Resonance Imaging (MRI) Contrast Agents Market Under COVID-19 8 Asia-Pacific Magnetic Resonance Imaging (MRI) Contrast Agents Market Analysis by Countries 8.1 Asia-Pacific Magnetic Resonance Imaging (MRI) Contrast Agents Sales, Revenue and Market Share by Countries 8.1.1 Asia-Pacific Magnetic Resonance Imaging (MRI) Contrast Agents Sales by Countries (2015-2020) 8.1.2 Asia-Pacific Magnetic Resonance Imaging (MRI) Contrast Agents Revenue by Countries (2015-2020) 8.1.3 Asia-Pacific Magnetic Resonance Imaging (MRI) Contrast Agents Market Under COVID-19 8.2 China Magnetic Resonance Imaging (MRI) Contrast Agents Sales and Growth Rate (2015-2020) 8.2.1 China Magnetic Resonance Imaging (MRI) Contrast Agents Market Under COVID-19 8.3 Japan Magnetic Resonance Imaging (MRI) Contrast Agents Sales and Growth Rate (2015-2020) 8.3.1 Japan Magnetic Resonance Imaging (MRI) Contrast Agents Market Under COVID-19 8.4 South Korea Magnetic Resonance Imaging (MRI) Contrast Agents Sales and Growth Rate (2015-2020) 8.4.1 South Korea Magnetic Resonance Imaging (MRI) Contrast Agents Market Under COVID-19 8.5 Australia Magnetic Resonance Imaging (MRI) Contrast Agents Sales and Growth Rate (2015-2020) 8.6 India Magnetic Resonance Imaging (MRI) Contrast Agents Sales and Growth Rate (2015-2020) 8.6.1 India Magnetic Resonance Imaging (MRI) Contrast Agents Market Under COVID-19 8.7 Southeast Asia Magnetic Resonance Imaging (MRI) Contrast Agents Sales and Growth Rate (2015-2020) 8.7.1 Southeast Asia Magnetic Resonance Imaging (MRI) Contrast Agents Market Under COVID-19 9 Middle East and Africa Magnetic Resonance Imaging (MRI) Contrast Agents Market Analysis by Countries 9.1 Middle East and Africa Magnetic Resonance Imaging (MRI) Contrast Agents Sales, Revenue and Market Share by Countries 9.1.1 Middle East and Africa Magnetic Resonance Imaging (MRI) Contrast Agents Sales by Countries (2015-2020) 9.1.2 Middle East and Africa Magnetic Resonance Imaging (MRI) Contrast Agents Revenue by Countries (2015-2020) 9.1.3 Middle East and Africa Magnetic Resonance Imaging (MRI) Contrast Agents Market Under COVID-19 9.2 Saudi Arabia Magnetic Resonance Imaging (MRI) Contrast Agents Sales and Growth Rate (2015-2020) 9.3 UAE Magnetic Resonance Imaging (MRI) Contrast Agents Sales and Growth Rate (2015-2020) 9.4 Egypt Magnetic Resonance Imaging (MRI) Contrast Agents Sales and Growth Rate (2015-2020) 9.5 Nigeria Magnetic Resonance Imaging (MRI) Contrast Agents Sales and Growth Rate (2015-2020) 9.6 South Africa Magnetic Resonance Imaging (MRI) Contrast Agents Sales and Growth Rate (2015-2020) 10 South America Magnetic Resonance Imaging (MRI) Contrast Agents Market Analysis by Countries 10.1 South America Magnetic Resonance Imaging (MRI) Contrast Agents Sales, Revenue and Market Share by Countries 10.1.1 South America Magnetic Resonance Imaging (MRI) Contrast Agents Sales by Countries (2015-2020) 10.1.2 South America Magnetic Resonance Imaging (MRI) Contrast Agents Revenue by Countries (2015-2020) 10.1.3 South America Magnetic Resonance Imaging (MRI) Contrast Agents Market Under COVID-19 10.2 Brazil Magnetic Resonance Imaging (MRI) Contrast Agents Sales and Growth Rate (2015-2020) 10.2.1 Brazil Magnetic Resonance Imaging (MRI) Contrast Agents Market Under COVID-19 10.3 Argentina Magnetic Resonance Imaging (MRI) Contrast Agents Sales and Growth Rate (2015-2020) 10.4 Columbia Magnetic Resonance Imaging (MRI) Contrast Agents Sales and Growth Rate (2015-2020) 10.5 Chile Magnetic Resonance Imaging (MRI) Contrast Agents Sales and Growth Rate (2015-2020) 11 Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Segment by Types 11.1 Global Magnetic Resonance Imaging (MRI) Contrast Agents Sales, Revenue and Market Share by Types (2015-2020) 11.1.1 Global Magnetic Resonance Imaging (MRI) Contrast Agents Sales and Market Share by Types (2015-2020) 11.1.2 Global Magnetic Resonance Imaging (MRI) Contrast Agents Revenue and Market Share by Types (2015-2020) 11.2 Extracellular fluid agents Sales and Price (2015-2020) 11.3 Blood pool agents Sales and Price (2015-2020) 11.4 Target/organ-specific agents Sales and Price (2015-2020) 12 Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Segment by Applications 12.1 Global Magnetic Resonance Imaging (MRI) Contrast Agents Sales, Revenue and Market Share by Applications (2015-2020) 12.1.1 Global Magnetic Resonance Imaging (MRI) Contrast Agents Sales and Market Share by Applications (2015-2020) 12.1.2 Global Magnetic Resonance Imaging (MRI) Contrast Agents Revenue and Market Share by Applications (2015-2020) 12.2 Diagnostic Imaging Sales, Revenue and Growth Rate (2015-2020) 12.3 Others Sales, Revenue and Growth Rate (2015-2020) 13 Magnetic Resonance Imaging (MRI) Contrast Agents Market Forecast by Regions (2020-2026) 13.1 Global Magnetic Resonance Imaging (MRI) Contrast Agents Sales, Revenue and Growth Rate (2020-2026) 13.2 Magnetic Resonance Imaging (MRI) Contrast Agents Market Forecast by Regions (2020-2026) 13.2.1 North America Magnetic Resonance Imaging (MRI) Contrast Agents Market Forecast (2020-2026) 13.2.2 Europe Magnetic Resonance Imaging (MRI) Contrast Agents Market Forecast (2020-2026) 13.2.3 Asia-Pacific Magnetic Resonance Imaging (MRI) Contrast Agents Market Forecast (2020-2026) 13.2.4 Middle East and Africa Magnetic Resonance Imaging (MRI) Contrast Agents Market Forecast (2020-2026) 13.2.5 South America Magnetic Resonance Imaging (MRI) Contrast Agents Market Forecast (2020-2026) 13.3 Magnetic Resonance Imaging (MRI) Contrast Agents Market Forecast by Types (2020-2026) 13.4 Magnetic Resonance Imaging (MRI) Contrast Agents Market Forecast by Applications (2020-2026) 13.5 Magnetic Resonance Imaging (MRI) Contrast Agents Market Forecast Under COVID-19 14 Appendix 14.1 Methodology 14.2 Research Data Source
Magnetic Resonance Imaging (MRI) Contrast Agents
Magnetic Resonance Imaging (MRI) Contrast Agents
×